Cargando…
A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial
Autores principales: | Nathan, Steven D., Medarov, Boris, Ho, Lawrence, Kingrey, John, Hong, Taekwon, Rao, Youlan, Shen, Eric, Smith, Peter, Deng, Chunqin, Waxman, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559141/ https://www.ncbi.nlm.nih.gov/pubmed/37413676 http://dx.doi.org/10.1513/AnnalsATS.202303-229RL |
Ejemplares similares
-
47 Shrinking Coarsened Win Ratio and Testing of Composite Endpoint
por: Mou, Yunhan, et al.
Publicado: (2023) -
The win ratio method: a novel hierarchical endpoint for pneumonia trials in patients on mechanical ventilation
por: Montgomery, A, et al.
Publicado: (2014) -
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial
por: Nathan, Steven D., et al.
Publicado: (2021) -
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
por: Wang, Duolao, et al.
Publicado: (2011) -
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study
por: Waxman, Aaron, et al.
Publicado: (2023)